GLP-1 receptor agonists and podocyte senescence in diabetic kidney disease: structural pharmacology, mechanistic evidence, and multi-receptor agonism.
- DOI
- 10.1016/j.bcp.2026.118495
- Published
- 2026 Sep 23
- Container
- Biochemical pharmacology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.bcp.2026.118495,
title = {GLP-1 receptor agonists and podocyte senescence in diabetic kidney disease: structural pharmacology, mechanistic evidence, and multi-receptor agonism.},
author = {Yue H and Wang Y and Guo X and Sun Y and Cheng Y and Yan P and Tan Z and Han C and Wang B},
year = {2026},
journal = {Biochemical pharmacology},
doi = {10.1016/j.bcp.2026.118495},
url = {https://doi.org/10.1016/j.bcp.2026.118495}
}RIS
TY - JOUR TI - GLP-1 receptor agonists and podocyte senescence in diabetic kidney disease: structural pharmacology, mechanistic evidence, and multi-receptor agonism. AU - Yue H AU - Wang Y AU - Guo X AU - Sun Y AU - Cheng Y AU - Yan P AU - Tan Z AU - Han C AU - Wang B PY - 2026 JO - Biochemical pharmacology DO - 10.1016/j.bcp.2026.118495 UR - https://doi.org/10.1016/j.bcp.2026.118495 ER -
APA
H, Y., Y, W., X, G., Y, S., Y, C., P, Y., Z, T., C, H., & B, W. (2026). GLP-1 receptor agonists and podocyte senescence in diabetic kidney disease: structural pharmacology, mechanistic evidence, and multi-receptor agonism.. Biochemical pharmacology. https://doi.org/10.1016/j.bcp.2026.118495
Source records
- pubmed · retrieved 2026-09-25T11:42:10.755Z